| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer | EVP &Chief Operating Officer | Chief Business Officer, Global
2 companies
Friedl-Naderer Johanna is an EVP &Chief Operating Officer at Vir Biotechnology, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 6 sells.
Estimated insider holdings value: $3.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 5, 2025 | DYN Dyne Therapeutics, Inc. | Chief Commercial Officer | Sell | 144 | $20.72 | $2,983.68 | -0.2% | -25.0% | - | |
| Sep 5, 2025 | DYN Dyne Therapeutics, Inc. | Chief Commercial Officer | Sell | 1,038 | $13.29 | $13,794.42 | -0.5% | +45.2% | - | |
| Jun 5, 2025 | DYN Dyne Therapeutics, Inc. | Chief Commercial Officer | Sell | 146 | $13.35 | $1,949.10 | -0.2% | -3.6% | - | |
| Mar 13, 2025 | DYN Dyne Therapeutics, Inc. | Chief Commercial Officer | Sell | 143 | $12.12 | $1,733.16 | -0.1% | +22.6% | +50.8% | |
| Mar 3, 2023 | VIR Vir Biotechnology, Inc. | EVP &Chief Operating Officer | Sell | 1,482 | $22.82 | $33,819.24 | -1.0% | +17.7% | -50.8% |